Società NeuroVive Pharmaceutical AB Swiss Exchange
Azioni
NVP
SE0002575340
Biotecnologia
Attività
Vendite per attività
SEK in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Mitochondrial Diseases
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +341,94% |
Vendite per regione
SEK in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Sweden
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +341,94% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Ellen Donnelly
CEO | Chief Executive Officer | 50 | 03/02/21 |
Eskil Elmér
FOU | Founder | 54 | 01/02/00 |
Director of Finance/CFO | 57 | 01/12/13 | |
Dag Nesse
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/02/23 |
Magnus Hansson
CTO | Chief Tech/Sci/R&D Officer | 48 | 01/01/08 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Chairman | 70 | 28/04/16 | |
David Bejker
BRD | Director/Board Member | 49 | 27/04/17 |
Eskil Elmér
FOU | Founder | 54 | 01/02/00 |
Roger Franklin
BRD | Director/Board Member | 45 | 20/05/20 |
Denise Goode
BRD | Director/Board Member | 66 | 27/04/18 |
Director/Board Member | 64 | 27/04/17 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 1 056 299 165 | 930 212 762 ( 88,06 %) | 0 | 88,06 % |
Coordinate società
![Indirizzo NeuroVive Pharmaceutical AB(NVP)](https://cdn.zonebourse.com/static/address/11050616.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
+20,95% | 127 Mrd | |
+23,00% | 116 Mrd | |
+25,15% | 27,69 Mrd | |
-19,75% | 19,62 Mrd | |
-16,57% | 16,26 Mrd | |
-16,56% | 15,49 Mrd | |
+11,19% | 14,81 Mrd | |
-46,65% | 14,39 Mrd | |
+57,74% | 14,11 Mrd |